Now I just want my life back." 2
Common side effects include nausea, vomiting, constipation, and mild diarrhea, especially during dose escalation
Retatrutide vs Ozempic - Retatrutide is triple-action
Disposition : Structure: Acylated peptide with a fatty diacid moiety extends half-life via albumin binding Half-life: ~6 days supports once-weekly dosing Administration: Subcutaneous injection Clinical Data Highlights : Weight Loss: Up to 24.2% body weight reduction in phase 2 trials, highest recorded among incretin-based therapies Glycemic Control: HbA1c reductions of 2.02.5% in type 2 diabetes patients Lipid Profile: Significant drops in triglycerides, LDL-C, and liver fat content Insulin Sensitivity: Improved HOMA-IR and fasting insulin levels Energy Expenditure: Increased basal metabolic rate and fat oxidation via glucagon receptor activation For a full breakdown of Retatrutide clinical trials and results you can click the link
Pharmacokinetic data from a clinical trial involving adolescent participants treated with 3.0 mg liraglutide daily showed a median liraglutide concentration of 29.4 nM at week 8, declining to 17.7 nM at week 56 (97)
Even in my bull case (3035 % obesity market share held longer, faster CapEx normalisation, successful oral pill leadership), the stock is only fairly valued to slightly cheap today
